Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pulmonary Drug Delivery Systems Market 2018, Forecast to 2023

Publisher Name :
Date: 12-Jun-2018
No. of pages: 154

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

Scope of the Report:

This report focuses on the Pulmonary Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.

As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.

The worldwide market for Pulmonary Drug Delivery Systems is expected to grow at a CAGR of roughly 5.3% over the next five years, will reach 3490 million US$ in 2023, from 2560 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- 3M

- GSK

- AstraZeneca

- Cipla

- Chiesi

- Boehringer Ingelheim

- Aptar

- Novartis

- Philips Respironics

- Omron Healthcare

- PARI

- Skyepharma

- CareFusion

- Shanghai Huarui

- Taian Character

- Chia Tai Tianqing

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Nebulizers

- Dry Powder Inhaler (DPI)

- Metered Dose Inhaler (MDI)

Market Segment by Applications, can be divided into

- COPD

- Asthma

- Others

There are 15 Chapters to deeply display the global Pulmonary Drug Delivery Systems market.

Chapter 1, to describe Pulmonary Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pulmonary Drug Delivery Systems, with sales, revenue, and price of Pulmonary Drug Delivery Systems, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pulmonary Drug Delivery Systems, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pulmonary Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pulmonary Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pulmonary Drug Delivery Systems Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Pulmonary Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Nebulizers
1.2.2 Dry Powder Inhaler (DPI)
1.2.3 Metered Dose Inhaler (MDI)
1.3 Market Analysis by Applications
1.3.1 COPD
1.3.2 Asthma
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 3M
2.1.1 Business Overview
2.1.1.1 3M Description
2.1.1.2 3M Headquarter, Main Business and Finance Overview
2.1.2 3M Pulmonary Drug Delivery Systems Product Introduction
2.1.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.1.2.2 Pulmonary Drug Delivery Systems Product Information
2.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global 3M Pulmonary Drug Delivery Systems Market Share in 2017
2.2 GSK
2.2.1 Business Overview
2.2.1.1 GSK Description
2.2.1.2 GSK Headquarter, Main Business and Finance Overview
2.2.2 GSK Pulmonary Drug Delivery Systems Product Introduction
2.2.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.2.2.2 Pulmonary Drug Delivery Systems Product Information
2.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GSK Pulmonary Drug Delivery Systems Market Share in 2017
2.3 AstraZeneca
2.3.1 Business Overview
2.3.1.1 AstraZeneca Description
2.3.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.3.2 AstraZeneca Pulmonary Drug Delivery Systems Product Introduction
2.3.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.3.2.2 Pulmonary Drug Delivery Systems Product Information
2.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global AstraZeneca Pulmonary Drug Delivery Systems Market Share in 2017
2.4 Cipla
2.4.1 Business Overview
2.4.1.1 Cipla Description
2.4.1.2 Cipla Headquarter, Main Business and Finance Overview
2.4.2 Cipla Pulmonary Drug Delivery Systems Product Introduction
2.4.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.4.2.2 Pulmonary Drug Delivery Systems Product Information
2.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Cipla Pulmonary Drug Delivery Systems Market Share in 2017
2.5 Chiesi
2.5.1 Business Overview
2.5.1.1 Chiesi Description
2.5.1.2 Chiesi Headquarter, Main Business and Finance Overview
2.5.2 Chiesi Pulmonary Drug Delivery Systems Product Introduction
2.5.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.5.2.2 Pulmonary Drug Delivery Systems Product Information
2.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Chiesi Pulmonary Drug Delivery Systems Market Share in 2017
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.1.1 Boehringer Ingelheim Description
2.6.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.6.2 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Introduction
2.6.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.6.2.2 Pulmonary Drug Delivery Systems Product Information
2.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Boehringer Ingelheim Pulmonary Drug Delivery Systems Market Share in 2017
2.7 Aptar
2.7.1 Business Overview
2.7.1.1 Aptar Description
2.7.1.2 Aptar Headquarter, Main Business and Finance Overview
2.7.2 Aptar Pulmonary Drug Delivery Systems Product Introduction
2.7.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.7.2.2 Pulmonary Drug Delivery Systems Product Information
2.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Aptar Pulmonary Drug Delivery Systems Market Share in 2017
2.8 Novartis
2.8.1 Business Overview
2.8.1.1 Novartis Description
2.8.1.2 Novartis Headquarter, Main Business and Finance Overview
2.8.2 Novartis Pulmonary Drug Delivery Systems Product Introduction
2.8.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.8.2.2 Pulmonary Drug Delivery Systems Product Information
2.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Novartis Pulmonary Drug Delivery Systems Market Share in 2017
2.9 Philips Respironics
2.9.1 Business Overview
2.9.1.1 Philips Respironics Description
2.9.1.2 Philips Respironics Headquarter, Main Business and Finance Overview
2.9.2 Philips Respironics Pulmonary Drug Delivery Systems Product Introduction
2.9.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.9.2.2 Pulmonary Drug Delivery Systems Product Information
2.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Philips Respironics Pulmonary Drug Delivery Systems Market Share in 2017
2.10 Omron Healthcare
2.10.1 Business Overview
2.10.1.1 Omron Healthcare Description
2.10.1.2 Omron Healthcare Headquarter, Main Business and Finance Overview
2.10.2 Omron Healthcare Pulmonary Drug Delivery Systems Product Introduction
2.10.2.1 Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.10.2.2 Pulmonary Drug Delivery Systems Product Information
2.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Omron Healthcare Pulmonary Drug Delivery Systems Market Share in 2017
2.11 PARI
2.11.1 Business Overview
2.11.2 PARI Pulmonary Drug Delivery Systems Product Introduction
2.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Skyepharma
2.12.1 Business Overview
2.12.2 Skyepharma Pulmonary Drug Delivery Systems Product Introduction
2.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 CareFusion
2.13.1 Business Overview
2.13.2 CareFusion Pulmonary Drug Delivery Systems Product Introduction
2.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Shanghai Huarui
2.14.1 Business Overview
2.14.2 Shanghai Huarui Pulmonary Drug Delivery Systems Product Introduction
2.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Taian Character
2.15.1 Business Overview
2.15.2 Taian Character Pulmonary Drug Delivery Systems Product Introduction
2.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Chia Tai Tianqing
2.16.1 Business Overview
2.16.2 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Introduction
2.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pulmonary Drug Delivery Systems Market Competition, by Manufacturer
3.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Pulmonary Drug Delivery Systems Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2017
3.4.2 Top 5 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Pulmonary Drug Delivery Systems Market Analysis by Regions
4.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Pulmonary Drug Delivery Systems Sales by Regions (2013-2018)
4.1.2 Global Pulmonary Drug Delivery Systems Revenue by Regions (2013-2018)
4.2 North America Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
5 North America Pulmonary Drug Delivery Systems by Countries, Type, Application and Manufacturers
5.1 North America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
5.1.2 North America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
5.1.3 United States Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.4 Canada Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.5 Mexico Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.2 North America Pulmonary Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Pulmonary Drug Delivery Systems Sales by Manufacturers (2016-2017)
5.2.2 North America Pulmonary Drug Delivery Systems Revenue by Manufacturers (2016-2017)
5.3 North America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Pulmonary Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
5.3.2 North America Pulmonary Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
5.4 North America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Pulmonary Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
5.4.2 North America Pulmonary Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
6 Europe Pulmonary Drug Delivery Systems by Countries, Type, Application and Manufacturers
6.1 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
6.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
6.1.3 Germany Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.4 UK Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.5 France Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.6 Russia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.7 Italy Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.2 Europe Pulmonary Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Pulmonary Drug Delivery Systems Sales by Manufacturers (2016-2017)
6.2.2 Europe Pulmonary Drug Delivery Systems Revenue by Manufacturers (2016-2017)
6.3 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Pulmonary Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Pulmonary Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Pulmonary Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Pulmonary Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Pulmonary Drug Delivery Systems by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
7.1.3 China Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.4 Japan Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.5 Korea Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.6 India Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
8 South America Pulmonary Drug Delivery Systems by Countries, Type, Application and Manufacturers
8.1 South America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
8.1.2 South America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
8.1.3 Brazil Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.4 Argentina Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.5 Colombia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.2 South America Pulmonary Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Pulmonary Drug Delivery Systems Sales by Manufacturers (2016-2017)
8.2.2 South America Pulmonary Drug Delivery Systems Revenue by Manufacturers (2016-2017)
8.3 South America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Pulmonary Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
8.3.2 South America Pulmonary Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
8.4 South America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Pulmonary Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
8.4.2 South America Pulmonary Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Pulmonary Drug Delivery Systems by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.4 UAE Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.5 Egypt Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.7 South Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
10 Global Pulmonary Drug Delivery Systems Market Segment by Type
10.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
10.2 Nebulizers Sales Growth and Price
10.2.1 Global Nebulizers Sales Growth (2013-2018)
10.2.2 Global Nebulizers Price (2013-2018)
10.3 Dry Powder Inhaler (DPI) Sales Growth and Price
10.3.1 Global Dry Powder Inhaler (DPI) Sales Growth (2013-2018)
10.3.2 Global Dry Powder Inhaler (DPI) Price (2013-2018)
10.4 Metered Dose Inhaler (MDI) Sales Growth and Price
10.4.1 Global Metered Dose Inhaler (MDI) Sales Growth (2013-2018)
10.4.2 Global Metered Dose Inhaler (MDI) Price (2013-2018)
11 Global Pulmonary Drug Delivery Systems Market Segment by Application
11.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2013-2018)
11.2 COPD Sales Growth (2013-2018)
11.3 Asthma Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Pulmonary Drug Delivery Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.2.2 Europe Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.2.4 South America Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
12.3 Pulmonary Drug Delivery Systems Market Forecast by Type (2018-2023)
12.3.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Type (2018-2023)
12.4 Pulmonary Drug Delivery Systems Market Forecast by Application (2018-2023)
12.4.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Pulmonary Drug Delivery Systems Picture
Table Product Specifications of Pulmonary Drug Delivery Systems
Figure Global Pulmonary Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Pulmonary Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Pulmonary Drug Delivery Systems by Types in 2017
Figure Nebulizers Picture
Table Major Manufacturers of Nebulizers
Figure Dry Powder Inhaler (DPI) Picture
Table Major Manufacturers of Dry Powder Inhaler (DPI)
Figure Metered Dose Inhaler (MDI) Picture
Table Major Manufacturers of Metered Dose Inhaler (MDI)
Figure Pulmonary Drug Delivery Systems Sales Market Share by Applications in 2017
Figure COPD Picture
Figure Asthma Picture
Figure Others Picture
Figure United States Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure France Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure China Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure India Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Table 3M Headquarter, Established, Main Business and Finance Overview (2017)
Table 3M Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table 3M Pulmonary Drug Delivery Systems Product
Table 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global 3M Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global 3M Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table GSK Pulmonary Drug Delivery Systems Product
Table GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global GSK Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Pulmonary Drug Delivery Systems Product
Table AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global AstraZeneca Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Cipla Headquarter, Established, Main Business and Finance Overview (2017)
Table Cipla Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Cipla Pulmonary Drug Delivery Systems Product
Table Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cipla Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Cipla Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Chiesi Headquarter, Established, Main Business and Finance Overview (2017)
Table Chiesi Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Chiesi Pulmonary Drug Delivery Systems Product
Table Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Chiesi Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Chiesi Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Product
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Boehringer Ingelheim Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Aptar Headquarter, Established, Main Business and Finance Overview (2017)
Table Aptar Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Aptar Pulmonary Drug Delivery Systems Product
Table Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aptar Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Aptar Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Novartis Pulmonary Drug Delivery Systems Product
Table Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Novartis Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Philips Respironics Headquarter, Established, Main Business and Finance Overview (2017)
Table Philips Respironics Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Philips Respironics Pulmonary Drug Delivery Systems Product
Table Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Philips Respironics Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Philips Respironics Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table Omron Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Omron Healthcare Pulmonary Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Omron Healthcare Pulmonary Drug Delivery Systems Product
Table Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Omron Healthcare Pulmonary Drug Delivery Systems Sales Market Share in 2017
Figure Global Omron Healthcare Pulmonary Drug Delivery Systems Revenue Market Share in 2017
Table PARI
Table PARI Pulmonary Drug Delivery Systems
Table Skyepharma
Table Skyepharma Pulmonary Drug Delivery Systems
Table CareFusion
Table CareFusion Pulmonary Drug Delivery Systems
Table Shanghai Huarui
Table Shanghai Huarui Pulmonary Drug Delivery Systems
Table Taian Character
Table Taian Character Pulmonary Drug Delivery Systems
Table Chia Tai Tianqing
Table Chia Tai Tianqing Pulmonary Drug Delivery Systems
Table Global Pulmonary Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Global Pulmonary Drug Delivery Systems Price by Manufacturer (2016-2017)
Figure Top 3 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Global Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Global Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales by Regions (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales Market Share by Regions (2013-2018)
Table Global Pulmonary Drug Delivery Systems Revenue by Regions (2013-2018)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2013
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2017
Figure North America Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Europe Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table North America Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table North America Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Sales Market Share by Countries in 2013
Figure North America Pulmonary Drug Delivery Systems Sales Market Share by Countries in 201
  • Global Pulmonary Drug Delivery Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood suppl......
  • 2018-2023 Global Dry Powder Inhaler Device Consumption Market Report
    Published: 06-Jun-2018        Price: US 4660 Onwards        Pages: 164
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Dry Powder Inhaler Device market for 2018-2023. A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellit......
  • 2018 Top 5 Dry Powder Inhaler Device Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 06-Jun-2018        Price: US 4960 Onwards        Pages: 148
    A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. The global total sales of dry powder inhaler device is nearly 49674 K units in 2015. As a high tech industry, the manufacturing technology of Dry Powder Inhaler Device is ......
  • Global Ultrasonic Nebulizer Market Data Survey Report 2025
    Published: 02-Jun-2018        Price: US 1500 Onwards        Pages: 77
    Summary The global Ultrasonic Nebulizer market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity......
  • China Ultrasonic Nebulizer Market Research Report 2018
    Published: 31-May-2018        Price: US 3400 Onwards        Pages: 99
    The global Ultrasonic Nebulizer market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Ultrasonic Nebulizer development status and future trend in China, focuses on top players in China, also splits Ultr......
  • Korea Ultrasonic Nebulizer Market Research Report 2018
    Published: 31-May-2018        Price: US 3400 Onwards        Pages: 95
    The global Ultrasonic Nebulizer market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Korea plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Ultrasonic Nebulizer development status and future trend in Korea, focuses on top players in Korea, also splits Ultr......
  • Global Intranasal Drug Delivery Devices Market Data Survey Report 2025
    Published: 31-May-2018        Price: US 1500 Onwards        Pages: 71
    Summary Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses. The global Intranasal Drug Delivery Devices market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:......
  • Asia-Pacific Intranasal Drug Delivery Devices Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 29-May-2018        Price: US 4480 Onwards        Pages: 107
    Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses. Scope of the Report: This report focuses on the Intranasal Drug Delivery Devices in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India an......
  • Global Drug Delivery Devices Market Professional Survey Report 2018
    Published: 28-May-2018        Price: US 3500 Onwards        Pages: 123
    This report studies Drug Delivery Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Cipla - Baxter International - Nipro Corporation - Roche......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs